Implementation of hepatitis C cure in Australia: one year on

OBJECTIVES: Direct-acting antivirals (DAAs) for the treatment of hepatitis C (HCV) became universally available in Australia in March 2016, with an aim to achieve HCV elimination. Fourteen per cent of Australians with HCV have initiated treatment. The objective of this study was to explore and ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Richmond, Jacqueline A, Wallace, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892669/
https://www.ncbi.nlm.nih.gov/pubmed/29682304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892669/
https://www.ncbi.nlm.nih.gov/pubmed/29682304

Ejemplares similares